Dallah Healthcare Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Dallah Healthcare Company operates, manages, and equips hospitals, medical centers, and clinics in Saudi Arabia. It also supplies pharmaceuticals, medical equipment, and diagnostics, and provides home nursing, physiotherapy, and remote-monitoring services. The company was founded in 1987 and is based in Riyadh.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 61.54 compared to a market price of SAR 83.30 (Trading above DCF model value). This is an analytical estimate, not investment advice.
Revenue and net income increased by a similar margin over the three-year period, up by about 38% and 40% respectively, indicating that profitability tracked closely with sales growth. Operating cash flow moved in the opposite direction, declining by about 11% over the same period, after rising in the second year and then falling in the third. Overall, the company's historical financial performance shows comparable growth in revenue and net income alongside a moderate decline in operating cash flow.
Dividend per share fluctuated over the 5-year recorded period, ranging between SAR 1.5 and SAR 2, and ended at SAR 1.5 versus SAR 2 at the start. Payments have been made on an Annual basis throughout this period. Overall, the company's per-share dividend has varied year to year without a consistent direction. Current dividend yield is approximately 2.40%, with a payout ratio of approximately 45.29%.
TASIV's Competitive Advantage assessment for this company is High (82/100), based on profitability, predictability, financial strength, and growth resilience.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Dallah Healthcare Co. is approximately SAR 61.54, compared to a current market price of SAR 83.30. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Dallah Healthcare Co. is currently "Trading above DCF model value".
Dallah Healthcare Co.'s dividend yield is approximately 2.40%, with a payout ratio of approximately 45.29%, based on TASIV's most recent verified data.
Loading 4004...